LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

BeOne Medicines Ltd ADR

Closed

SectorHealthcare

254.32 -4.58

Overview

Share price change

24h

Current

Min

252.72

Max

264.97

Key metrics

By Trading Economics

Income

153M

1.3M

Sales

-11M

1.1B

Profit margin

0.114

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+24.96% upside

Dividends

By Dow Jones

Next Earnings

6 Aug 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

258.9

Previous close

254.32

BeOne Medicines Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

12 May 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 Jan 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 Nov 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 Nov 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

22 Oct 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

7 May 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 May 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 May 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 May 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 May 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 Feb 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

7 Aug 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

7 Aug 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

24.96% upside

12 Months Forecast

Average 333.78 USD  24.96%

High 359.47 USD

Low 300 USD

Based on 8 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd